2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With AsthmaHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderEnrolling by invitationPhase 22026-09-21NCT06609239
Isatuximab in Combination With Novel Agents in RRMM - Master ProtocolPlasma Cell Myeloma RefractoryRecruitingPhase 1 / Phase 22026-06-16NCT04643002